共 158 条
[21]
Englot DJ(2020)Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES) Epilepsia 61 647-1187
[22]
Chang EF(2006)ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes Epilepsia 47 1094-2104
[23]
Vecht CJ(2020)Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome CNS Oncol 9 Cns53-591
[24]
Chen DY(2007)Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2389-1075
[25]
Chen CC(1988)A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1141-43
[26]
Crawford JR(2018)Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review Cochrane Database Syst Rev 6 Cd001031-17
[27]
Wang SG(2007)The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial Lancet 369 1000-undefined
[28]
Vecht C(2013)Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article J Neurosurg 118 1183-undefined
[29]
Royer-Perron L(2011)Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability J Neurol 258 2100-undefined
[30]
Houillier C(2020)Mechanisms of action of currently used antiseizure drugs Neuropharmacology. 168 107966-undefined